EADO/WCM 2025 | Latest revision of the Japanese guidelines for melanoma treatment

Satoshi Fukushima • 3 Apr 2025

EADO/WCM 2025

Melanoma Skin Cancer

Satoshi Fukushima, MD, PhD, Kumamoto University, Kumamoto, Japan, discusses the importance of revising Japanese guidelines for melanoma care, highlighting the need to analyze data from large-scale clinical trials in Western countries and real-world data from East Asia, particularly in the context of systemic therapy for acral and mucosal melanoma. This interview took place at the 11th World Congress of Melanoma and 21st EADO Congress in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.